Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)Abnormalities, Multiple, Adenoma, Islet Cell, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenoma, angiomatosis, cardiovascular disorder, endocrine system disorder, epithelial neoplasm, hereditary disease, malignant endocrine neoplasm, neoplasm, nervous system disorder, neurocutaneous syndrome, neuroendocrine neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine tumor, paraganglioma, pheochromocytoma, pheochromocytoma-paraganglioma, primitive neuroectodermal tumor, vascular disorder, von Hippel-Lindau diseaseRecruitingPhase 22026-10-06NCT04924075

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Merck Sharp & Dohme LLC650

84 results · Page 1 of 4

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Addenbrooke's Hospital ( Site 1309)CambridgeUnited Kingdom1
Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 1201)UppsalaSweden1
Ankara Bilkent Şehir Hastanesi. ( Site 0904)AnkaraTurkey (Türkiye)1
Arthur J.E. Child Comprehensive Cancer Centre ( Site 0203)CalgaryCanada1
Asan Medical Center ( Site 2000)Songpa-guSouth Korea1
Azienda Ospedaliera Spedali Civili di Brescia-Oncology ( Site 0701)BresciaItaly1
Azienda Ospedaliero Universitaria Senese-U.O.C. Immunoterapia Oncologica ( Site 0706)SienaItaly1
Baskent University Adana Training Hospital ( Site 0906)YüreğirTurkey (Türkiye)1
Cedars-Sinai Medical Center ( Site 0110)Los AngelesUnited States1
Centro de Oncología de Precisión ( Site 2203)SantiagoChile1
Centro Ricerche Cliniche di Verona ( Site 0703)VeronaItaly1
Charité Universitaetsmedizin Berlin - Campus Mitte-Department of Endocrinology and Metabolism ( Site 0503)BerlinGermany1
CHU Strasbourg-Hautepierre-Medecine Interne, Endocrinologie et Nutrition ( Site 0402)StrasbourgFrance1
Comprehensive Cancer Center Mainfranken-Div. of Endocrinology and Diabetes ( Site 0500)WürzburgGermany1
Ege University Medicine of Faculty ( Site 0900)BornovaTurkey (Türkiye)1
Endocrinology Research Center of Rosmedtechnologies-Surgery ( Site 0809)MoscowRussia1
Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF ( Site 0801)MoscowRussia1
Fondazione IRCCS Istituto Nazionale dei Tumori-S.C. Oncologia Medica 2- Sarcomi ( Site 0709)MilanItaly1
Fundación Arturo López Pérez ( Site 2200)SantiagoChile1
GBUZ Republican Clinical Oncological Dispensary ( Site 0804)UfaRussia1
Gustave Roussy ( Site 0403)VillejuifFrance1
Hacettepe Universitesi-oncology hospital ( Site 0901)AnkaraTurkey (Türkiye)1
Hammersmith Hospital-Medical Oncology ( Site 1304)LondonUnited Kingdom1
Hokkaido University Hospital ( Site 1800)SapporoJapan1
Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 0404)ParisFrance1